Association Analysis Between Methylation of SCARB1 Gene Promoter and Coronary Heart Disease.
10.3881/j.issn.1000-503X.15488
- Author:
Wei LI
1
;
Zhen-Hua WANG
1
;
Peng SHI
1
;
Song XUE
1
Author Information
1. Department of Cardiovascular Surgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China.
- Publication Type:Journal Article
- Keywords:
DNA methylation;
coronary heart disease;
promoter;
scavenger receptor class B member 1
- MeSH:
Male;
Humans;
Female;
Methylation;
Case-Control Studies;
China;
Coronary Artery Disease/genetics*;
Promoter Regions, Genetic;
DNA Methylation;
Scavenger Receptors, Class B/genetics*
- From:
Acta Academiae Medicinae Sinicae
2023;45(3):405-409
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the relationship between scavenger receptor class B member 1 (SCARB1) gene promoter methylation and the pathogenesis of coronary artery disease. Methods A total of 120 patients with coronary heart disease treated in Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine from December 2018 to May 2020 were selected as the case group,while 140 gender and age matched healthy participants were randomly selected as the control group for a case-control study.The methylation status was detected by high-throughput target sequencing after bisulfite converting,and the methylation of CpG sites in the promoter region of SCARB1 gene was compared between the two groups. Results The case group showed higher methylation level of SCARB1+67 and lower methylation level of SCARB1+134 than the control group (both P<0.001),and the differences remained statistically significant in men (both P<0.001) and women (both P<0.001).The overall methylation level in the case group was lower than that in the control group [(80.27±2.14)% vs.(81.11±1.27)%;P=0.006],while this trend was statistically significant only in men (P=0.002). Conclusion The methylation of SCARB1 gene promotor is associated with the pathogenesis and may participate in the occurrence and development of coronary heart disease.
